Cargando…

Doxorubicin-induced ovarian toxicity

BACKGROUND: Young cancer patients may occasionally face infertility and premature gonadal failure. Apart from its direct effect on follicles and oocytes, chemotherapy may induce ovarian toxicity via an impact on the entire ovary. The role of doxorubicin in potential ovarian failure remains obscure....

Descripción completa

Detalles Bibliográficos
Autores principales:	Ben-Aharon, Irit, Bar-Joseph, Hadas, Tzarfaty, Galia, Kuchinsky, Lital, Rizel, Shulamith, Stemmer, Salomon M, Shalgi, Ruth
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2838903/ https://www.ncbi.nlm.nih.gov/pubmed/20202194 http://dx.doi.org/10.1186/1477-7827-8-20

Ejemplares similares

In vivo Bioimaging as a Novel Strategy to Detect Doxorubicin-Induced Damage to Gonadal Blood Vessels
por: Bar-Joseph, Hadas, et al.
Publicado: (2011)

Doxorubicin-Induced Vascular Toxicity – Targeting Potential Pathways May Reduce Procoagulant Activity
por: Ben Aharon, Irit, et al.
Publicado: (2013)

Premature ovarian aging in BRCA carriers: a prototype of systemic precocious aging?
por: Ben-Aharon, Irit, et al.
Publicado: (2018)

Treosulfan induces distinctive gonadal toxicity compared with busulfan
por: Levi, Mattan, et al.
Publicado: (2018)

Anti-HER2/neu Antibody Reduces Chemotherapy-Induced Ovarian Toxicity—From Bench to Bedside
por: Levi, Mattan, et al.
Publicado: (2020)

Bisphosphonates in the Adjuvant Setting of Breast Cancer Therapy—Effect on Survival: A Systematic Review and Meta-Analysis
por: Ben-Aharon, Irit, et al.
Publicado: (2013)

Cancer During Pregnancy: The Role of Vascular Toxicity in Chemotherapy-Induced Placental Toxicity
por: Bar-Joseph, Hadas, et al.
Publicado: (2020)

miR-125a Induces HER2 Expression and Sensitivity to Trastuzumab in Triple-Negative Breast Cancer Lines
por: Ninio-Many, Lihi, et al.
Publicado: (2020)

Factors Affecting Communication Patterns between Oncology Staff and Family Members of Deceased Patients: A Cross-Sectional Study
por: Granot, Tal, et al.
Publicado: (2016)

Irinotecan (CPT-11) Treatment Induces Mild Gonadotoxicity
por: Levi, Mattan, et al.
Publicado: (2022)

Pretreatment with gonadotropin-releasing hormone antagonist protects against chemotherapy-induced testicular damage ‘in mice
por: Levi, Mattan, et al.
Publicado: (2022)

MicroRNA miR-125a-3p modulates molecular pathway of motility and migration in prostate cancer cells
por: Ninio-Many, Lihi, et al.
Publicado: (2014)

Adjuvant Docetaxel and Cyclophosphamide (DC) with Prophylactic Granulocyte Colony-Stimulating Factor (G-CSF) on Days 8 &12 in Breast Cancer Patients: A Retrospective Analysis
por: Yerushalmi, Rinat, et al.
Publicado: (2014)

The Impact of Bevacizumab (Avastin) on Survival in Metastatic Solid Tumors - A Meta-Analysis and Systematic Review
por: Amit, Limor, et al.
Publicado: (2013)

Correction: The Impact of Bevacizumab (Avastin) on Survival in Metastatic Solid Tumors - A Meta-Analysis and Systematic Review
por: Amit, Limor, et al.
Publicado: (2013)

The impact of the 21-gene Recurrence Score assay on clinical decision-making in node-positive (up to 3 positive nodes) estrogen receptor-positive breast cancer patients
por: Stemmer, Salomon M., et al.
Publicado: (2013)

Dose-Dense Chemotherapy in Nonmetastatic Breast Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials
por: Bonilla, Luisa, et al.
Publicado: (2010)

Phase II Study of Concurrent Capecitabine and External Beam Radiotherapy for Pain Control of Bone Metastases of Breast Cancer Origin
por: Kundel, Yulia, et al.
Publicado: (2013)

The Role of PEDF in Reproductive Aging of the Ovary †
por: Nemerovsky, Luba, et al.
Publicado: (2022)

TULP1 and TUB Are Required for Specific Localization of PRCD to Photoreceptor Outer Segments
por: Remez, Lital, et al.
Publicado: (2020)

Clinical outcomes in ER+ HER2 -node-positive breast cancer patients who were treated according to the Recurrence Score results: evidence from a large prospectively designed registry
por: Stemmer, Salomon M., et al.
Publicado: (2017)

BRCA1/2 mutations perturb telomere biology: characterization of structural and functional abnormalities in vitro and in vivo
por: Uziel, Orit, et al.
Publicado: (2015)

Regulation of GVBD in mouse oocytes by miR-125a-3p and Fyn kinase through modulation of actin filaments
por: Grossman, Hadas, et al.
Publicado: (2017)

Psychological tendencies of children with juvenile idiopathic arthritis
por: Badarnee, Muhammad, et al.
Publicado: (2022)

Ten-year clinical outcomes in N0 ER+ breast cancer patients with Recurrence Score-guided therapy
por: Stemmer, Salomon M., et al.
Publicado: (2019)

Comparison of Poly (ADP-ribose) Polymerase Inhibitors (PARPis) as Maintenance Therapy for Platinum-Sensitive Ovarian Cancer: Systematic Review and Network Meta-Analysis
por: Stemmer, Amos, et al.
Publicado: (2020)

The Association between Treatment for Metabolic Disorders and Breast Cancer Characteristics
por: Goldvaser, Hadar, et al.
Publicado: (2016)

The association between smoking and breast cancer characteristics and outcome
por: Goldvaser, Hadar, et al.
Publicado: (2017)

An intronic deletion in the PROM1 gene leads to autosomal recessive cone-rod dystrophy
por: Eidinger, Osnat, et al.
Publicado: (2015)

Breast Cancer during Pregnancy—Current Paradigms, Paths to Explore
por: Alfasi, Ayelet, et al.
Publicado: (2019)

Evolving treatment paradigms in esophageal cancer
por: Turgeman, Ilit, et al.
Publicado: (2021)

Young-Onset Cancers—Early Steps in the Right Direction
por: Barreto, Savio George, et al.
Publicado: (2023)

Systematic Evaluations of Doxorubicin-Induced Toxicity in Rats Based on Metabolomics
por: Geng, Chunmei, et al.
Publicado: (2020)

LCZ696 ameliorates doxorubicin-induced cardiomyocyte toxicity in rats
por: Miyoshi, Toru, et al.
Publicado: (2022)

Glycine protects against doxorubicin-induced heart toxicity in mice
por: Shosha, Mayada I., et al.
Publicado: (2023)

Adolescents With Cancer Need Trustworthy Information and Prefer to Receive It From a Human Source Rather Than From the Internet: A Qualitative Study
por: Schwartz-Attias, Irit, et al.
Publicado: (2021)

Concomitant Kinase-Dead BRAF and Oncogenic KRAS Lead to an Aggressive Biologic Behavior and Tumor Lysis Syndrome: A Case Report
por: Holland, Roy, et al.
Publicado: (2022)

Clinical outcomes in patients with node-negative breast cancer treated based on the recurrence score results: evidence from a large prospectively designed registry
por: Stemmer, Salomon M., et al.
Publicado: (2017)

A Switching Mechanism in Doxorubicin Bioactivation Can Be Exploited to Control Doxorubicin Toxicity
por: Finn, Nnenna A., et al.
Publicado: (2011)

Analysis of the Doxorubicin and Doxorubicinol in the Plasma of Breast Cancer Patients for Monitoring the Toxicity of Doxorubicin
por: Harahap, Yahdiana, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nlm4cpb538hiuklpb4jvg67r2n